AIDS Clinical Trials Group Spotlights on Amita Gupta

Date: 02/19/2015

Publication:

ACTG Spotlight

The AIDS Clinical Trials Group (ACTG) Network recognizes researchers and staff actively doing great work.  Spotlight highlights Dr. Gupta’s work in TB research in India.

Meet Amita Gupta

As a child, Amita Gupta, MD, witnessed infectious diseases firsthand while visiting extended family in India.

“I spent summers in India and saw the effects of polio, hepatitis B, tuberculosis and malaria,” she says. “Then when I was in college, I was galvanized by the world of HIV activism. I found myself more and more interested in working on HIV, volunteering at AIDS Action and Fenway Health in Boston. I later worked on HIV/AIDS at the Massachusetts Health Department.”

Read the complete article.
 

Clinical Trials

P1077BF: Breastfeeding Version of the PROMISE Study...

1077BF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...

Read More

P2010: Phase III Study of the Virologic Efficacy and Safety...

IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...

Read More

IMPAACT 2034 - Phase I Study of the Pharmacokinetics,...

This is a Phase I, multi-site, open-label, non-comparative study of the PK, safety, tolerability, and acceptability of a...

Read More

NWCS 408: Examining Longitudinal Cytokine Profiles in HIV-TB...

Using existing data from A5274 and data obtained from retrospectively testing available biospecimens, we propose the following...

Read More

HPTN 069: A Phase II Randomized, Double-Blind, Study of the...

HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...

Read More